---
document_datetime: 2025-09-11 14:12:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/menveo-epar-all-authorised-presentations_en.pdf
document_name: menveo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.018393
conversion_datetime: 2025-12-25 12:13:25.567187
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                            | Route of Administration   | Immediate Packaging                                                                                 | Content (concentration)   | Pack size           |
|------------------|-------------------|------------|------------------------------------------------|---------------------------|-----------------------------------------------------------------------------------------------------|---------------------------|---------------------|
| EU/1/10/614/002  | Menveo            | --¹        | Powder and solution for solution for injection | Intramuscular use         | MenA lyophilised conjugate component: vial (glass); MenCWY liquid conjugate component: vial         | 0.5 ml                    | 5 vials + 5 vials   |
| EU/1/10/614/003  | Menveo            | --¹        | Powder and solution for solution for injection | Intramuscular use         | (glass) MenA lyophilised conjugate component: vial (glass); MenCWY liquid conjugate component: vial | 0.5 ml                    | 1 vial + 1 vial     |
| EU/1/10/614/004  | Menveo            | --¹        | Powder and solution for solution for injection | Intramuscular use         | MenA lyophilised conjugate component: vial (glass); MenCWY liquid conjugate component: vial (glass) | 0.5 ml                    | 10 vials + 10 vials |
| EU/1/10/614/005  | Menveo            | --¹        | Solution for injection                         | Intramuscular use         | vial (glass)                                                                                        | 0.5 ml                    | 1 vial              |
| EU/1/10/614/006  | Menveo            | --¹        | Solution for injection                         | Intramuscular use         | vial (glass)                                                                                        | 0.5 ml                    | 10 vials            |

Meningococcal group A oligosaccharide 10 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 16.7 to 33.3 micrograms Meningococcal group C oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 7.1 to 12.5 micrograms Meningococcal group W135 oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 3.3 to 8.3 micrograms Meningococcal group Y oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 5.6 to 10.0 micrograms